The future of chemotherapy lies in combination therapies, integrating traditional chemotherapeutic agents with new modalities like immunotherapy and CAR-T cell therapy. Ongoing research aims to develop more precise, less toxic drugs and to optimize treatment regimens to enhance patient outcomes.
